GFACX
Price
$73.27
Change
-$0.59 (-0.80%)
Updated
Jun 3 closing price
Net Assets
337.53B
SMMSX
Price
$30.74
Change
+$0.38 (+1.25%)
Updated
Jun 2 closing price
Net Assets
3.68B
Interact to see
Advertisement

GFACX vs SMMSX

Header iconGFACX vs SMMSX Comparison
Open Charts GFACX vs SMMSXBanner chart's image
GFACX vs SMMSX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. SMMSX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and SMMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. SMMSX (3.68B). GFACX (0.00) and SMMSX (0.00) have matching dividends . GFACX was incepted earlier than SMMSX: GFACX (25 years) vs SMMSX (17 years). GFACX (1.35) is less costly to investors than SMMSX (0.87). SMMSX is a more actively managed with annual turnover of: 58.00 vs. GFACX (32.00). SMMSX has a lower initial minimum investment than GFACX: SMMSX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 11.27 vs. SMMSX (6.51). GFACX return over 5 years is better than : 13.16 vs. SMMSX (-2.69).
GFACXSMMSXGFACX / SMMSX
Total Expense Ratio1.350.87155%
Annual Report Gross Expense Ratio1.350.87155%
Fund Existence25 years17 years-
Gain YTD9.7479.123107%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets338B3.68B9,187%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.276.51173%
Returns for 3 years43.8954.0981%
Returns for 5 years13.16-2.69-489%
Returns for 10 years87.5690.3797%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDX29.770.87
+3.01%
Celldex Therapeutics
NRT8.170.09
+1.11%
North European Oil Royalty Trust
NYT75.17-0.07
-0.09%
New York Times Co
ESEA65.25-0.56
-0.85%
Euroseas Ltd
ADTX0.09-0.02
-15.30%
Aditxt Inc.